Research
Education
Healthcare
Community
About
Sep 07, 2023 | National Institute on Aging
Specialized dementia care in nursing homes linked to better outcomes for residents
Nursing home residents with Alzheimer’s disease or a related dementia have better outcomes when their facility specializes in dementia care, according to an NIA-funded study led by Dana B. Mukamel, PhD, professor in the Department of Medicine.
Sep 07, 2023 | Forbes
Health Benefits Of Cannabis, According To Experts
Daniele Piomelli, PhD, director of the UCI Center for the Study of Cannabis and professor in the Department of Anatomy & Neurobiology, talks to Forbes about cannabis and its potential health risks.
Sep 06, 2023 | Prevention
The New Middle Age: What Is Middle Age and Does It Really Mean What We Think?
Sonia R. Sehgal, MD, professor in the Department of Medicine, talks to Prevention about what "middle age" is.
Sep 05, 2023 | NBC News
The U.S. has a chance to regulate delta-8 THC. Will it?
Daniele Piomelli, PhD, director for the UCI Center for the Study of Cannabis, and professor in the Department of Anatomy & Neurobiology, talks to NBC News about how legislation that is meant to protect public health has created loopholes that now jeopardize public health.
Sep 05, 2023 | Wired
Ozempic and Wegovy Can Also Protect Your Heart
Nathan D. Wong, PhD, professor and director of the Heart Disease Prevention Program in the Division of Cardiology, talks to Wired about recent research that shows how semaglutide medication may benefit 93 million U.S. adults.
UCI School of Medicine Research Insider
September 5, 2023
Sep 03, 2023 | Irvine Standard
UCI welcomes new students
UCI School of Medicine welcomes the class of 2027 at its annual White Coat Ceremony.
August 29, 2023
Aug 29, 2023 | UC Irvine School of Medicine
UC Irvine researchers discover a nanobody which may lead to treatment for Retinitis Pigmentosa
A special antibody derived from llamas — called a nanobody — can stop the misfolding and the activation of Rhodopsin, a molecule whose mutations can lead to blindness.
Aug 28, 2023 | UC Irvine School of Medicine
Researchers at UC Irvine issue a warning that GLP-1RAs may be dangerous for children
The use of glucagon-like peptide-1 receptor agonists in popular weight loss drugs like Ozempic and Wegovy could threaten pediatric health.